Effects of β-blockers on ventilation efficiency in heart failure
详细信息    查看全文
文摘

Background

Hyperventilation and consequent reduction of ventilation (VE) efficiency are frequently observed during exercise in heart failure (HF) patients, resulting in an increased slope of VE/carbon dioxide (VE/Vco2) relationship. The latter is an independent predictor of HF prognosis. β-Blockers improve the prognosis of HF patients. We evaluated the effect on the efficiency of VE of a β12 unselective (carvedilol) versus a β1 selective (bisoprolol) β-blocker.

Methods

We analyzed consecutive maximal cardiopulmonary exercise tests performed on 572 clinically stable HF patients (New York Heart Association class I-III, left ventricle ejection fraction ≤50 % ) categorized in 3 groups: 81 were not treated with β-blocker, 304 were treated with carvedilol, and 187 were treated with bisoprolol. Clinical conditions were similar.

Results

The VE/Vco2 slope was lower in carvedilol- compared with bisoprolol-treated patients (29.7 ± 0.4 vs 31.6 ± 0.5, P = .023, peak oxygen consumption adjusted) and with patients not receiving β-blockers (31.6 ± 0.7, P = .036). Maximum end-tidal CO2 pressure during the isocapnic buffering period was higher in patients treated with carvedilol (39.0 ± 0.3 mm Hg) than with bisoprolol (37.2 ± 0.4 mm Hg, P < .001) and in patients not receiving β-blockers (37.2 ± 0.5 mm Hg, P = .001).

Conclusions

Reduction of hyperventilation, with improvement of VE efficiency during exercise (reduction of VE/Vco2 slope and increase of maximum end-tidal CO2 pressure), is specific to carvedilol (β12 unselective blocker) and not to bisoprolol (β1-selective blocker).

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700